Procter & Gamble Overview
Procter & Gamble (P&G) is the worlds largest consumer goods company and home to iconic, trusted brands, including Always, Charmin, Braun, Fairy, Febreze, Gillette, Head & Shoulders, Oral B, Pantene, Pampers, Tide, and Vicks. In 2007, P&G established the Israel House of Innovation with the goal of establishing a multi-disciplinary, open innovation network scouting for P&Gs most complex problems. It brings disruptive solutions to P&G within their areas of interest. P&G Israel combined newly discovered innovation from Israel with their economy of scale, and the opportunities that arise from working within a global corporation.
Latest News
growth-positive
Rivian downgraded, PayPal upgraded: Wall Street's top analyst calls
Barclays upgraded SolarEdge (SEDG) to Equal Weight from Underweight with a price target of $29, up from $12. The firm believes the One Big Beautiful Bill creates an uneven playing field for loans and cash in solar versus leases, and now expects SolarEdge to see 20% sales growth. This upgrade is part of a broader set of research calls that include both upgrades and downgrades for various companies, reflecting market analysts expectations and strategic insights. The article highlights the potential for SolarEdge to experience significant sales growth, driven by favorable market conditions.
growth-negative
Nigeria's Currency Crisis Is Fueling a Corporate Exodus
Procter & Gamble Co. is among several global conglomerates exiting Nigeria due to a scarcity of dollars needed to repatriate earnings, unreliable electricity supply, and port congestion. Other companies leaving include GSK Plc, Bayer AG, and Sanofi SA. The exits will exacerbate pressure on the naira, which has depreciated 86% over the last eight years. The Nigerian government is implementing measures to revive the economy and attract businesses, but many companies cant wait. The exits present an opportunity for local manufacturers, but they are also struggling with the economic conditions.
CustomersPartners
P&G to Weigh $1 Billion Sale of VS Sassoon’s China Business
growth-positive
"We pre-vet P&G business units' readiness to collaborate with startups" | CTech
The article features Orr Hameiri, the global tech innovation director at Procter & Gamble (P&G), who discusses his role in leading innovation and working with startups. Hameiri explains that P&G aims to become clients of startups and create win-win situations. He emphasizes the importance of partnerships and investments in startups that align with P&Gs goals. Hameiri also highlights the need for clear success metrics and a structured process for scaling innovative solutions within the company. The article showcases P&Gs commitment to innovation and its openness to external inventions.
PartnersExpand
growth-negative
Teva, Procter & Gamble terminate OTC venture
Teva Pharmaceutical Industries has agreed to terminate its partnership with Procter & Gamble to market OTC medicines. The separation will take effect on July 1, 2018. No significant financial transfer will result from the dissolution. Teva and P&G concluded that their priorities and strategies were no longer closely aligned. Teva will take back its own brand and product assets to re-establish an independent OTC business. The separation is not expected to have a material impact on Tevas 2018 financial outlook. Teva will merge its OTC interests returning from PGT with a portfolio of OTC assets acquired in 2016. In 2017, the combined sales from Tevas PGT OTC products and Teva non-PGT OTC products were about $1 billion.
Partners
Team Members
2
Employees: 51-200
Web & Social Links
| Website | www.pgisrael.co.il/ |
Locations
HaNechoshet St 6, Tel Aviv-Yafo, Israel
Cincinnati, OH, USA
Photos & Videos
1 item(s)
